Regulation of Acetylation of Histone Deacetylase 2 by p300/CBP-Associated Factor/Histone Deacetylase 5 in the Development of Cardiac Hypertrophy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation Research

• Publication date

  2014-03-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.114.303429PMID 24526703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noncommunicable Diseases

  2018cited by this paper
• Noncommunicable diseases.

  2013cited by this paper
• Pluripotent Stem Cells

  2013cited by this paper
• Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.

  2012cited by this paper
• Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage.

  2011cited by this paper
• Casein Kinase-2&agr;1 Induces Hypertrophic Response by Phosphorylation of Histone Deacetylase 2 S394 and its Activation in the Heart

  2011cited by this paper
• Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension.

  2011cited by this paper
• Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes.

  2010cited by this paper
• Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy.

  2009cited by this paper
• Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

  2009cited by this paper
• HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells.

  2009cited by this paper
• S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons

  2008cited by this paper
• HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment

  2008cited by this paper
• Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells.

  2008cited by this paper
• Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure.

  2008cited by this paper
• Epigenetic histone acetylation modifiers in vascular remodelling – new targets for therapy in cardiovascular disease

  2008cited by this paper
• Activation of Histone Deacetylase 2 by Inducible Heat Shock Protein 70 in Cardiac Hypertrophy

  2008cited by this paper
• Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.

  2008cited by this paper
• Differential Distribution of Unmodified and Phosphorylated Histone Deacetylase 2 in Chromatin*

  2007cited by this paper
• Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression

  2006cited by this paper
• Histone Acetyltransferase Activity of p300 Is Required for the Promotion of Left Ventricular Remodeling After Myocardial Infarction in Adult Mice In Vivo

  2006cited by this paper
• Sumoylation and Acetylation Play Opposite Roles in the Transactivation of PLAG1 and PLAGL2*

  2005cited by this paper
• Inhibition of Histone Deacetylation Blocks Cardiac Hypertrophy Induced by Angiotensin II Infusion and Aortic Banding

  2005cited by this paper
• Acetylation and deacetylation of non-histone proteins.

  2005cited by this paper
• Histone Deacetylases 5 and 9 Govern Responsiveness of the Heart to a Subset of Stress Signals and Play Redundant Roles in Heart Development

  2004cited by this paper
• Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5

  2004cited by this paper
• Nicotinamide Clearance by Pnc1 Directly Regulates Sir2-Mediated Silencing and Longevity

  2004cited by this paper
• The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression

  2004cited by this paper
• Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure

  2003cited by this paper
• Cardiac hypertrophy: the good, the bad, and the ugly.

  2003cited by this paper
• Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation

  2003cited by this paper
• Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

  2003cited by this paper
• The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

  2003cited by this paper
• Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.

  2003cited by this paper
• What is known

  2003cited by this paper
• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation

  2002cited by this paper
• Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB

  2002cited by this paper
• Regulation of Histone Deacetylase 2 by Protein Kinase CK2*

  2002cited by this paper
• Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.

  2002influential reference
• Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

  2002cited by this paper
• HDAC6 is a microtubule-associated deacetylase

  2002cited by this paper
• Measurement of Cardiac Mechanical Function in Isolated Ventricular Myocytes from Rats and Mice by Computerized Video-Based Imaging

  2001cited by this paper
• Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.

  2001cited by this paper
• The β2-Adrenergic Receptor Mediates Extracellular Signal-regulated Kinase Activation via Assembly of a Multi-receptor Complex with the Epidermal Growth Factor Receptor*

  2000cited by this paper
• The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor.

  2000cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• DNA damage activates p53 through a phosphorylation-acetylation cascade.

  1998cited by this paper
• Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.

  1998cited by this paper
• Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper

• Current opinion in cardiology, epigenetics of heart failure.

  2026cites this paper
• Interleukin-16 upregulates tissue inhibitor of metalloproteinase 3 to promote atherosclerotic plaque stability

  2026cites this paper
• Epigenetic Mechanisms in Heart Diseases

  2025cites this paper
• Unlocking cardiac health: exploring the role of class I HDACs in cardiovascular diseases

  2025cites this paper
• Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases

  2025cites this paper
• H1.0 modulates IL-6 expression and paclitaxel resistance via HDAC5 in ovarian cancer cells.

  2025cites this paper
• Downregulation of HDAC2 attenuates ventricular arrhythmias in a mouse model of cardiac hypertrophy through upregulation of KCHIP2 expression.

  2025cites this paper
• Galangin 3-methyl ether alleviates mouse hypertrophic cardiomyopathy via targeting HDAC2 and subsequently inactivating the PI3K-AKT signaling pathway

  2025cites this paper
• Targeting histone deacetylases for heart diseases.

  2023cites this paper
• Mass Spectrometry-Based Quantitative Proteomics Analysis for Better Understanding of Telomeric Zinc Finger-Associated Protein-Induced Pathogenesis in Cardiomyocytes.

  2022cites this paper
• Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology

  2022cites this paper
• Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification

  2022cites this paper
• Dynamics of metabolism and regulation of epigenetics during cardiomyocytes maturation

  2022cites this paper
• Therapeutic potential of HDAC inhibitors in the treatment of cardiac diseases: A short review.

  2022cites this paper
• HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer

  2022cites this paper
• Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases

  2022cites this paper
• Circ-Ddx60 contributes to the antihypertrophic memory of exercise hypertrophic preconditioning.

  2022cites this paper
• HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer

  2022cites this paper
• The Role of Post-Translational Acetylation and Deacetylation of Signaling Proteins and Transcription Factors after Cerebral Ischemia: Facts and Hypotheses

  2021cites this paper
• S-Nitrosylation of Histone Deacetylase 2 by Neuronal Nitric Oxide Synthase as a Mechanism of Diastolic Dysfunction

  2021cites this paper
• Understanding the Genetic and Molecular Basis of Familial Hypertrophic Cardiomyopathy and the Current Trends in Gene Therapy for Its Management

  2021cites this paper
• Systemic study of selected HDAC inhibitors in cardiac complications associated with cancer cachexia.

  2021cites this paper
• P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation

  2021cites this paper
• The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies

  2021cites this paper
• Function of histone methylation and acetylation modifiers in cardiac hypertrophy.

  2021cites this paper
• Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2

  2020cites this paper
• Roles of Histone Acetylation Modifiers and Other Epigenetic Regulators in Vascular Calcification

  2020cites this paper
• Phosphoproteomic Analysis of Potato Tuber Reveals a Possible Correlation Between Phosphorylation Site Occupancy and Protein Attributes

  2020cites this paper
• Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications.

  2020cites this paper
• The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

  2020cites this paper
• Critical review of non‐histone human substrates of metal‐dependent lysine deacetylases

  2020cites this paper
• Phosphoproteomic Analysis of Potato Tuber Reveals a Possible Correlation Between Phosphorylation Site Occupancy and Protein Attributes

  2020cites this paper
• Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications

  2020cites this paper
• PCAF Involvement in Lamin A/C-HDAC2 Interplay during the Early Phase of Muscle Differentiation

  2020influential citation
• HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases

  2019cites this paper
• Heart failure with preserved ejection fraction: present status and future directions

  2019cites this paper
• Exploring the Continuum of Hypertrophic Cardiomyopathy—From DNA to Clinical Expression

  2019cites this paper
• Anacardic acid attenuates pressure‐overload cardiac hypertrophy through inhibiting histone acetylases

  2019cites this paper
• Experimental models of cardiac physiology and pathology

  2019cites this paper
• Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2.

  2019cites this paper
• Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells

  2019cites this paper
• Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure

  2018cites this paper
• Quantitative Crotonylome Analysis Expands the Roles of p300 in the Regulation of Lysine Crotonylation Pathway

  2018cites this paper
• PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart

  2018cites this paper
• Deacetylation of Histone H4 Accompanying Cardiomyogenesis is Weakened in HDAC1-Depleted ES Cells

  2018cites this paper
• New Aspects of Vascular Calcification: Histone Deacetylases and Beyond

  2017influential citation
• Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes

  2017cites this paper
• Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures*

  2017cites this paper
• The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons.

  2017influential citation
• Metabolism and chromatin dynamics in health and disease.

  2017cites this paper
• Theranostic biomarkers in hypertrophic cardiomyopathy: insights in a long road ahead.

  2017cites this paper
• Proteomic analysis of the protective effects of aqueous bark extract of Terminalia arjuna (Roxb.) on isoproterenol-induced cardiac hypertrophy in rats.

  2017influential citation
• Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common and Systemic Tumour Signatures

  2017cites this paper
• Therapeutic Potential for Natural Product HDAC Inhibitors in Heart Failure

  2017cites this paper
• MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification

  2016cites this paper
• HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases

  2016cites this paper
• Mechanisms of transcription factor acetylation and consequences in hearts.

  2016cites this paper
• Epigenetic and Nongenomic Roles for Histone Deacetylases in Heart Failure

  2016cites this paper
• Inhibition of different histone acetyltransferases (HATs) uncovers transcription-dependent and -independent acetylation-mediated mechanisms in memory formation

  2016cites this paper
• Epigenetic regulation of cardiac fibrosis.

  2016cites this paper
• Inhibition of histone deacetylases in melanoma—a perspective from bench to bedside

  2016cites this paper
• Recent Developments in Stem and Progenitor Cell Therapy for Cardiac Repair.

  2016cites this paper
• HDAC5 controls the functions of Foxp3+ T‐regulatory and CD8+ T cells

  2016cites this paper
• Studies Towards Broadening The Substrate Profile And Regulation Of Histone Deacetylase 1

  2016influential citation
• Regulation of Nox enzymes expression in vascular pathophysiology: Focusing on transcription factors and epigenetic mechanisms

  2015cites this paper
• The Specificity and Regulation of Human Histone Deacetylase 8.

  2015influential citation
• Diabetic cardiomyopathy: Phenotypes, mechanisms, and therapeutic targets

  2015cites this paper
• Readers, writers, and erasers: chromatin as the whiteboard of heart disease.

  2015cites this paper
• Epigenetic regulation in cardiac fibrosis.

  2015cites this paper
• Effect of the angiotensin II receptor blocker valsartan on cardiac hypertrophy and myocardial histone deacetylase expression in rats with aortic constriction.

  2015cites this paper
• Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy

  2015cites this paper
• Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice

  2015cites this paper
• Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy

  2015cites this paper
• Chromatin as the Whiteboard of Heart Disease

  2015cites this paper
• Non-sirtuin histone deacetylases in the control of cardiac aging.

  2015cites this paper
• The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice.

  2014cites this paper
• Epigenetic regulation of cardiac myocyte differentiation†

  2014cites this paper
• Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.

  2014cites this paper
• Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms

  2014cites this paper
• Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis.

  2014cites this paper